Showing results (1761-1770 of 1,877) with videos related to

Sort By:
Pageof 188
Annals of Surgical Treatment and Research|December 13, 2024
Development of the Korean Quality Improvement Platform in Surgery (K-QIPS) program: a nationwide project to improve surgical quality and patient safetyJeong-Moo Lee, In Woong Han, Oh Chul Kwon, et al.
Annals of Hematology|September 28, 2018
Efficacy and safety of blinatumomab treatment in adult Korean patients with relapsed/refractory acute lymphoblastic leukemia on behalf of the Korean Society of Hematology ALL Working PartySung-Hoon Jung, Se-Ryeon Lee, Deok-Hwan Yang, et al.
Cancer Research and Treatment|July 16, 2024
Assessing the Efficacy of Bortezomib and Dexamethasone for Induction and Maintenance Therapy in Relapsed/Refractory Cutaneous T-Cell Lymphoma: A Phase II CISL1701/BIC StudyYoon Seok Choi, Joonho Shim, Ka-Won Kang, et al.
The Korean Journal of Internal Medicine|January 30, 2024
Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort studyHo-Young Yhim, Yong Park, Jeong-A Kim, et al.
Cancer Genetics and Cytogenetics|December 16, 2010
GSTT1 copy number gain is a poor predictive marker for escalated-dose imatinib treatment in chronic myeloid leukemia: genetic predictive marker found using array comparative genomic hybridizationYoungil Koh, Dae-Young Kim, Sung-Hyo Park, et al.
Journal of Medicinal Chemistry|August 4, 2021
Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CLpro)Sang Hoon Han, Christopher M Goins, Tarun Arya, et al.
The Journal of Obstetrics and Gynaecology Research|December 10, 2019
Effectiveness of adjuvant treatment for morcellated, International Federation of Gynecology and Obstetrics stage I uterine leiomyosarcoma: A Korean multicenter studySe Ik Kim, Chel Hun Choi, Kidong Kim, et al.
Seizure|January 12, 2018
Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsyByung In Lee, Soon Kee No, Sang-Doe Yi, et al.
Nature Communications|March 30, 2024
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trialChanghee Park, Ho Sup Lee, Ka-Won Kang, et al.
Blood|June 12, 2026
Anbalcabtagene autoleucel (PD-1 and TIGIT knockdown CD19 CAR-T) for relapsed/refractory large B-cell lymphoma (CRC01-01)Won Seog Kim, Seok Jin Kim, Dok Hyun Yoon, et al.
Pageof 188